Cargando…
Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis
The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high mortality and morbidity among patients with comorbidities. This viral infection promotes the perfect setting in patients for the development of opportunistic infections, such as those caused by fungi. Mucormycosis,...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144279/ https://www.ncbi.nlm.nih.gov/pubmed/35628701 http://dx.doi.org/10.3390/jof8050445 |
_version_ | 1784716010156195840 |
---|---|
author | García-Carnero, Laura C. Mora-Montes, Héctor M. |
author_facet | García-Carnero, Laura C. Mora-Montes, Héctor M. |
author_sort | García-Carnero, Laura C. |
collection | PubMed |
description | The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high mortality and morbidity among patients with comorbidities. This viral infection promotes the perfect setting in patients for the development of opportunistic infections, such as those caused by fungi. Mucormycosis, a rare but deadly fungal infection, has recently increased its incidence, especially in endemic areas, since the onset of the pandemic. COVID-19-associated mucormycosis is an important complication of the pandemic because it is a mycosis hard to diagnose and treat, causing concern among COVID-19-infected patients and even in the already recovered population. The risk factors for the development of mucormycosis in these patients are related to the damage caused by the SARS-CoV-2 itself, the patient’s overstimulated immune response, and the therapy used to treat COVID-19, causing alterations such as hyperglycemia, acidosis, endothelial and lung damage, and immunosuppression. In this review, the molecular aspects of mucormycosis and the main risk factors for the development of COVID-19-associated mucormycosis are explained to understand this virus–fungi–host interaction and highlight the importance of this neglected mycosis. |
format | Online Article Text |
id | pubmed-9144279 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-91442792022-05-29 Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis García-Carnero, Laura C. Mora-Montes, Héctor M. J Fungi (Basel) Review The ongoing COVID-19 pandemic has quickly become a health threat worldwide, with high mortality and morbidity among patients with comorbidities. This viral infection promotes the perfect setting in patients for the development of opportunistic infections, such as those caused by fungi. Mucormycosis, a rare but deadly fungal infection, has recently increased its incidence, especially in endemic areas, since the onset of the pandemic. COVID-19-associated mucormycosis is an important complication of the pandemic because it is a mycosis hard to diagnose and treat, causing concern among COVID-19-infected patients and even in the already recovered population. The risk factors for the development of mucormycosis in these patients are related to the damage caused by the SARS-CoV-2 itself, the patient’s overstimulated immune response, and the therapy used to treat COVID-19, causing alterations such as hyperglycemia, acidosis, endothelial and lung damage, and immunosuppression. In this review, the molecular aspects of mucormycosis and the main risk factors for the development of COVID-19-associated mucormycosis are explained to understand this virus–fungi–host interaction and highlight the importance of this neglected mycosis. MDPI 2022-04-25 /pmc/articles/PMC9144279/ /pubmed/35628701 http://dx.doi.org/10.3390/jof8050445 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review García-Carnero, Laura C. Mora-Montes, Héctor M. Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis |
title | Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis |
title_full | Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis |
title_fullStr | Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis |
title_full_unstemmed | Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis |
title_short | Mucormycosis and COVID-19-Associated Mucormycosis: Insights of a Deadly but Neglected Mycosis |
title_sort | mucormycosis and covid-19-associated mucormycosis: insights of a deadly but neglected mycosis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144279/ https://www.ncbi.nlm.nih.gov/pubmed/35628701 http://dx.doi.org/10.3390/jof8050445 |
work_keys_str_mv | AT garciacarnerolaurac mucormycosisandcovid19associatedmucormycosisinsightsofadeadlybutneglectedmycosis AT moramonteshectorm mucormycosisandcovid19associatedmucormycosisinsightsofadeadlybutneglectedmycosis |